癌症患者对 COVID-19 疫苗的免疫反应：有希望的结果和谨慎的提示。
Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution.
机构信息
Leukemia Division, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Department of Internal Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
出版信息
Cancer Cell. 2021 Aug 9;39(8):1045-1047. doi: 10.1016/j.ccell.2021.07.001. Epub 2021 Jul 3.
SARS-CoV-2 vaccines are effective in preventing COVID-19. Patients with cancer are at high risk for severe COVID-19 and are appropriately prioritized for vaccination. Several studies in this issue of Cancer Cell add to our knowledge of the heterogeneity of immune responses to vaccination among patients with cancer and identify important areas for future research.
SARS-CoV-2 疫苗可有效预防 COVID-19。癌症患者罹患重症 COVID-19 的风险较高，因此应优先接种疫苗。本期《癌细胞》中的几项研究增加了我们对癌症患者疫苗接种免疫反应异质性的认识，并确定了未来研究的重要领域。
Zotero 插件